Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Internal Medicine and Rehabilitation Science, Tohoku University Graduate School of Medicine, Sendai, Japan.
Int J Cardiol. 2021 Apr 1;328:14-21. doi: 10.1016/j.ijcard.2020.12.003. Epub 2020 Dec 9.
In vasospastic angina (VSA), coronary vasomotion abnormalities could develop not only in epicardial coronary arteries but also in coronary microvessels, where calcium channel blockers (CCBs) have limited efficacy. However, efficacy of exercise training for VSA remains to be elucidated. We thus aimed to examine whether vasodilator capacity of coronary microvessels is impaired in VSA patients, and if so, whether exercise exerts beneficial effects on the top of CCBs.
We performed 2 clinical protocols. In the protocol 1, we measured myocardial blood flow (MBF) using adenosine-stress dynamic computed tomography perfusion (CTP) in 38 consecutive VSA patients and 17 non-VSA controls. In the protocol 2, we conducted randomized controlled trial, where 20 VSA patients were randomly assigned to either 3-month exercise training group (Exercise group) or Non-Exercise group (n= 10 each).
In the protocol 1, MBF on CTP was significantly decreased in the VSA group compared with the Non-VSA group (138 ± 6 vs 166 ± 10 ml/100 g/min, P = 0.02). In the protocol 2, exercise capacity was significantly increased in the Exercise group than in the Non-Exercise group (11.5 ± 0.5 to 15.4 ± 1.8 vs 12.6 ± 0.7 to 14.0 ± 0.8 ml/min/kg, P < 0.01). MBF was also significantly improved after 3 months only in the Exercise group (Exercise group, 145 ± 12 to 172 ± 8 ml/100 g/min, P < 0.04; Non-Exercise group, 143 ± 14 to 167 ± 8 ml/100 g/min, P = 0.11), although there were no significant between-group differences.
These results provide the first evidence that, in VSA patients, exercise training on the top of CCBs treatment may be useful to improve physical performance, although its effect on MBF may be minimal.
在痉挛性心绞痛(VSA)中,不仅心外膜冠状动脉,而且在冠状动脉微血管中也会出现冠状动脉运动异常,而钙通道阻滞剂(CCB)在此类病变中的疗效有限。然而,运动训练对 VSA 的疗效仍有待阐明。因此,我们旨在研究 VSA 患者的冠状动脉微血管扩张能力是否受损,如果是,那么运动是否在 CCB 治疗的基础上具有有益作用。
我们进行了 2 项临床研究。在方案 1 中,我们使用腺苷应激动态计算机断层灌注(CTP)测量了 38 例连续 VSA 患者和 17 例非 VSA 对照组的心肌血流(MBF)。在方案 2 中,我们进行了随机对照试验,其中 20 例 VSA 患者被随机分为 3 个月的运动训练组(运动组)或非运动组(每组 10 例)。
在方案 1 中,与非 VSA 组相比,VSA 组的 CTP 上的 MBF 明显降低(138±6 与 166±10ml/100g/min,P=0.02)。在方案 2 中,与非运动组相比,运动组的运动能力明显提高(11.5±0.5 至 15.4±1.8 与 12.6±0.7 至 14.0±0.8ml/min/kg,P<0.01)。仅在运动组中,经过 3 个月的治疗,MBF 也明显改善(运动组,145±12 至 172±8ml/100g/min,P<0.04;非运动组,143±14 至 167±8ml/100g/min,P=0.11),尽管两组之间无显著差异。
这些结果首次提供了证据表明,在 VSA 患者中,在 CCB 治疗的基础上进行运动训练可能有助于提高运动能力,尽管其对 MBF 的影响可能很小。